---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024835"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T07:13:40.444886+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TenX Keane extends business combination deadline to Oct 18, 2023 with $660k deposit

## Summary
- Deposited $660k ($0.10 per public share) into trust to extend business combination deadline.
- Deadline extended from July 18, 2023 to October 18, 2023.
- Sponsor 10XYZ Holdings LP provided funds via unsecured promissory note.
- Note convertible up to $1.5M into private units at $10/unit upon business combination.
- Extension is first of up to three possible 3-month extensions.

## SEC filing metadata
- accession: 0001493152-23-024835
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315223024835/0001493152-23-024835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315223024835/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024835
- JSON: https://secwatch.observer/filing/0001493152-23-024835.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024835.txt

## Key facts
- Debt Financings
  CITIUS ONCOLOGY, INC. incurred convertible notes of $660,000 with 10XYZ Holdings LP at bears no interest maturing upon the consummation of the Company's business combination.
  - Instrument: convertible notes
  - Principal: $660,000
  - Counterparty: 10XYZ Holdings LP
  - Rate: bears no interest
  - Maturity: upon the consummation of the Company's business combination
  - Event: incurrence
  source text: On July 18, 2023, the Company deposited $660,000 into the trust account of the Company (the “Extension Fee”) to extend the timeline to complete a business combination for an additional three months from July 18, 2023 to October 18, 2023 (the “Extension”). Such deposit of the Extension Fee is evidenced by an unsecured promissory note (the “Promissory Note”) in the principal amount of $660,000 to the Sponsor. The Promissory Note bears no interest and is payable in full upon the consummation of the Company’s business combination (such date, the “Maturity Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851484/000149315223024835/0001493152-23-024835-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.